Healthcare -
Biotechnology - NASDAQ - US
$ 2.625
1.74 %
$ 140 M
Market Cap
-2.76
P/E
TCRX - TOTAL CURRENT LIABILITIES
Total Current Liabilities TCRX - TScan Therapeutics, Inc.
29.8 M
LAST VALUE
18.20%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR